Skip to main content
Clinical Trials/NCT03529461
NCT03529461
Completed
Not Applicable

Use of Non-Invasive Positive Pressure Ventilation in Patients With Severe Obesity Undergoing Upper Endoscopy Procedures

Bristol Hospital1 site in 1 country56 target enrollmentApril 25, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Severe Obesity
Sponsor
Bristol Hospital
Enrollment
56
Locations
1
Primary Endpoint
Percentage of Participants With an Oxygen Desaturation Event ≤ 94%
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The study evaluated the effect of non-invasive positive pressure ventilation (NIPPV) to decrease the incidence of desaturation events in patients with severe obesity undergoing upper endoscopy.

Detailed Description

Patients being evaluated for bariatric surgery often undergo preoperative upper endoscopy. Patients with obesity are at increased risk for sedation related adverse events during endoscopy. The study evaluated the effect of non-invasive positive pressure ventilation (NIPPV) to decrease the incidence of desaturation in patients with severe obesity undergoing upper endoscopy. The study was a randomized controlled trial that assessed the effectiveness of NIPPV in patients undergoing upper endoscopy. Patients were randomized into experimental group NIPPV or control group. Primary endpoints were desaturation events (SpO2 \<=94%) and desaturation events requiring intervention (SpO2\<=90%). A secondary endpoint was the use of NIPPV to rescue patients who developed a clinically significant desaturation event.

Registry
clinicaltrials.gov
Start Date
April 25, 2017
End Date
April 18, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Sponsor
Bristol Hospital
Responsible Party
Principal Investigator
Principal Investigator

Makram Gedeon, MD

Medical director of bariatric surgery program, principal investigator

Bristol Hospital

Eligibility Criteria

Inclusion Criteria

  • Weight loss surgery patients undergoing preoperative upper endoscopy
  • BMI 40-60

Exclusion Criteria

  • Pregnant patients
  • Previous weight loss surgery or stomach surgery
  • BMI \> 60 and BMI \< 40
  • Active smokers
  • Patients with a history of recent URTI (Upper Respiratory Tract Infection) within the preceding 2 weeks
  • Lung disease, COPD asthma, cystic fibrosis, sarcoidosis
  • Baseline O2 saturation less than or equal to 94%
  • Exclude substance abusers (active alcohol abuse, benzodiazepine abuse, and active illicit drug use)

Outcomes

Primary Outcomes

Percentage of Participants With an Oxygen Desaturation Event ≤ 94%

Time Frame: Time in seconds beginning with the start of procedure (anesthesia induction) ending with procedure completion (eyes open to verbal stimuli).

Percentage of participants who develop a peripheral oxygen saturation measured by pulse oximetry ≤ 94%

Percentage of Participants With an Oxygen Desaturation Event < 90%

Time Frame: Time in seconds beginning with the start of procedure (anesthesia induction) ending with procedure completion (eyes open to verbal stimuli).

Percentage of participants who develop a peripheral oxygen saturation event \< 90%.

Secondary Outcomes

  • Percentage of Participants in the Control Group With an Oxygen Saturation Less Than 90 % Who Responded to Rescue NIPPV(3 minutes following a desaturation event < 90 %)

Study Sites (1)

Loading locations...

Similar Trials